Cargando…
Cryoablation and immunotherapy: an overview of evidence on its synergy
Cancer cells can escape the immune system by different mechanisms. The evasion of cancer cells from immune surveillance is prevented by immune checkpoint inhibitors, allowing the patient’s own immune system to attack their cancer. Immune checkpoint inhibitors have shown improvement in overall surviv...
Autores principales: | Aarts, B. M., Klompenhouwer, E. G., Rice, S. L., Imani, F., Baetens, T., Bex, A., Horenblas, S., Kok, M., Haanen, J. B. A. G., Beets-Tan, R. G. H., Gómez, F. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6527672/ https://www.ncbi.nlm.nih.gov/pubmed/31111237 http://dx.doi.org/10.1186/s13244-019-0727-5 |
Ejemplares similares
-
Percutaneous cryoablation: a novel treatment option in non-visceral metastases of the abdominal cavity after prior surgery
por: van der Reijd, D. J., et al.
Publicado: (2022) -
Percutaneous Microwave Ablation of Histologically Proven T1 Renal Cell Carcinoma
por: Aarts, B. M., et al.
Publicado: (2020) -
Cryoablation and Immunotherapy: An Enthralling Synergy to Confront the Tumors
por: Yakkala, Chakradhar, et al.
Publicado: (2019) -
Cryoablation and Immunotherapy: An Enthralling Synergy for Cancer Treatment
por: Medlej, Zain al Abidine, et al.
Publicado: (2023) -
Safety and efficacy of RFA versus MWA for T1a renal cell carcinoma: a propensity score analysis
por: Aarts, Brigit M., et al.
Publicado: (2022)